ReP USP - Resultado da busca

Filtros : "Cancers" "GLIOMA" Removido: "Brunner, Carlos Henrique Maciel" Limpar

Filtros

USP affiliated authors
- alves, venancio avancini ferreira (1)
- arévalo, analía leonora (1)
- baptista, mauricio da silva (1)
- barbuto, jose alexandre marzagao (1)
- bento, nataly peres carvalho (1)

Date published
- 2023 (~2)
Subjects
- células cultivadas de tumor (2)
- glioma (2)
- neoplasias cerebrais (2)
- adjuvantes imunológicos (1)
- antidiabéticos (hipoglicemiantes) (1)

Artigo de periodico
Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial (2023)
Lepski, Guilherme ; Bergami-Santos, Patricia C. ; Pinho, Mariana P. ; Chauca-Torres, Nadia E. ; Evangelista, Gabriela C. M. ; Teixeira, Sarah F. ; Flatow, Elizabeth ; Oliveira, Jaqueline V. de ; Fogolin, Carla ; Peres, Nataly ; Arévalo, Analía ; Alves, Venâncio A. F. ; Barbuto, José Alexandre Marzagão
Source: Cancers. Unidades: FM, ICB
Subjects: IMUNOLOGIA, NEOPLASIAS CEREBRAIS, GLIOMA, IMUNOTERAPIA, ADJUVANTES IMUNOLÓGICOS, CÉLULAS DENDRÍTICAS, ASTROCITOMA, CÉLULAS CULTIVADAS DE TUMOR, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEPSKI, Guilherme et al. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, v. 15, n. 4, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15041239. Acesso em: 18 nov. 2024.
APA
Lepski, G., Bergami-Santos, P. C., Pinho, M. P., Chauca-Torres, N. E., Evangelista, G. C. M., Teixeira, S. F., et al. (2023). Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, 15( 4), 1-12. doi:10.3390/cancers15041239
NLM
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15041239
Vancouver
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15041239
Artigo de periodico
GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status (2023)
Moretti, Isabele Fattori ; Lerario, Antonio Marcondes ; Sola, Paula Rodrigues ; Silva, Janaína Macedo da; Baptista, Mauricio da Silva ; Palmisano, Giuseppe ; Shinjo, Sueli Mieko Oba ; Marie, Suely Kazue Nagahashi
Source: Cancers. Unidades: FM, IQ, ICB
Subjects: PARASITOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS CEREBRAIS, GLIOMA, LIPOPOLISSACARÍDEOS, ANTIOXIDANTES, ANTIDIABÉTICOS (HIPOGLICEMIANTES), ESTRESSE OXIDATIVO, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORETTI, Isabele Fattori et al. GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status. Cancers, v. 15, n. 3, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15030587. Acesso em: 18 nov. 2024.
APA
Moretti, I. F., Lerario, A. M., Sola, P. R., Silva, J. M. da, Baptista, M. da S., Palmisano, G., et al. (2023). GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status. Cancers, 15( 3), 1-18. doi:10.3390/cancers15030587
NLM
Moretti IF, Lerario AM, Sola PR, Silva JM da, Baptista M da S, Palmisano G, Shinjo SMO, Marie SKN. GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status [Internet]. Cancers. 2023 ; 15( 3): 1-18.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15030587
Vancouver
Moretti IF, Lerario AM, Sola PR, Silva JM da, Baptista M da S, Palmisano G, Shinjo SMO, Marie SKN. GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status [Internet]. Cancers. 2023 ; 15( 3): 1-18.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15030587

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024